Compare Flux Power Holdings Inc (FLUX) vs Recursion Pharmaceuticals Inc (RXRX) Price & Performance
Price performance (Past 24H)
Key statistics
Key statistics
Flux Power Holdings Inc vs Recursion Pharmaceuticals Inc — how do they compare? Flux Power Holdings Inc trades at $0.58 (market cap $11.23M), while Recursion Pharmaceuticals Inc trades at $3.35 (market cap $1.81B). The key difference: Recursion Pharmaceuticals Inc is far larger — about 161.2× Flux Power Holdings Inc's market cap, and Recursion Pharmaceuticals Inc is trading nearer its 52-week high, Flux Power Holdings Inc nearer its low. Which is the better fit depends on your goals.
| FLUX | RXRX | |
|---|---|---|
Market Cap | $11.23M | $1.81B |
Sector | Utilities | Health |
52-Week High | $6.66 | $6.79 |
52-Week Low | $0.51 | $2.84 |
Enterprise Value | $17.39M | $1.33B |
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
FLUX trades at $0.535, up 0.66% with a bearish technical signal despite 100% analyst buy ratings. The company reported mixed earnings with Q4 2025 beating expectations but Q1 2026 missing, while revenue declined from $66M in 2025 to $51M in 2026. Recent product launches like SkyEMS 3.0 and executive appointments aim to drive growth amid negative profitability metrics.
The outlook remains challenged by persistent net losses and negative ROE, though low P/S ratio and strong analyst support offer potential upside if operational improvements materialize. Key risks include cash flow volatility and competitive pressure in the clean energy sector.
No Aura AI signal available yet.
Returns comparison
Trailing returns across standard periods
Returns comparison
Trailing returns across standard periods
Top news
Latest headlines on both assets
Top news
Latest headlines on both assets
About Flux Power Holdings Inc
Flux Power designs and manufactures lithium-ion battery packs for industrial vehicles. Its sustainable energy solutions power material handling equipment like forklifts and airport ground support vehicles.
Read more on FLUX →About Recursion Pharmaceuticals Inc
Recursion Pharmaceuticals, Inc. is a clinical-stage biotechnology company leveraging artificial intelligence (AI) and machine learning to industrialize drug discovery. The company's unique approach combines one of the world's largest biological and chemical datasets with automated wet-lab and computational systems to map human biology and identify potential therapeutic candidates across a range of diseases, including oncology and rare diseases. Recursion aims to accelerate the traditionally slow and expensive process of drug development.
Read more on RXRX →
